Calithera Biosciences, Inc. CALA
0.00 USD 0.00 (-66.67%)
Regular-session close
0.0001 Day range 0.0001
0.0001 52-week range 0.001
- YTD
- 0.00%
- 1 year
- -90.00%
News
defenseworld.net Calithera Biosciences (NASDAQ:CALA) Shares Break Above 50 Day Moving Average – What’s Next? Shares of Calithera Biosciences, Inc. (NASDAQ: CALA - Get Free Report) passed above its 50-day moving average during trading on Friday. The stock has a 50-day moving average of $0.00 and traded as…
gurufocus.com Vistance Networks Reports Second Quarter 2026 Results Vistance Networks, Inc. (NASDAQ: VISN), a global leading provider of intelligent network solutions, today reported results for the quarter ended June 30, 2026.*
defenseworld.net Calithera Biosciences (NASDAQ:CALA) Shares Pass Above Fifty Day Moving Average – What’s Next? Calithera Biosciences, Inc. (NASDAQ: CALA - Get Free Report)'s share price passed above its fifty day moving average during trading on Monday. The stock has a fifty day moving average of $0.00 and…
defenseworld.net Merck KGaA (OTCMKTS:MKGAF) & Calithera Biosciences (NASDAQ:CALA) Head to Head Contrast Institutional and Insider Ownership 0.1% of Merck KGaA shares are held by institutional investors. 6.6% of Calithera Biosciences shares are held by company insiders. Strong institutional ownership is…
defenseworld.net Calithera Biosciences (NASDAQ:CALA) Stock Passes Above Fifty Day Moving Average – Time to Sell? Calithera Biosciences, Inc. (NASDAQ: CALA - Get Free Report)'s stock price passed above its fifty day moving average during trading on Friday. The stock has a fifty day moving average of $0.00 and…
prnewswire.com Marriott International Announces Changes to its Continent Leadership and a Strategic Realignment Across Key Regions Unified structure for U.S., Canada & CALA under Satya Anand's leadership; Neal Jones to lead EMEA; Federico "Fede" Greppi to head CALA; retirements of Marriott veterans Liam Brown and Brian King…
seekingalpha.com Calithera Biosciences, Inc. (CALA) Q3 2022 Earnings Call Transcript Calithera Biosciences, Inc. (NASDAQ:CALA ) Q3 2022 Earnings Conference Call November 14, 2022 5:00 PM ET Company Participants Stephanie Wong - CFO & Secretary Susan Molineaux - Founder, CEO,…
globenewswire.com Calithera Biosciences to Report Third Quarter 2022 Financial Results on Monday, November 14, 2022 SOUTH SAN FRANCISCO, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision-oncology biopharmaceutical company, today announced Company's…
marketwatch.com Calithera's stock is up 14% after announcing Fast Track designation for lung-cancer drug candidate Shares of Calithera Biosciences Inc. CALA, -0.68% jumped 14.6% in premarket trading on Monday after the company said it received a Fast Track designation for its experimental treatment for non-small…
investorplace.com 3 Penny Stocks With Surprisingly Superior Fundamentals The question of when to add risk to a portfolio is a difficult one to answer. A rush toward riskier equities after the pandemic-induced sell-off led to a surge in many stocks.
globenewswire.com Calithera to Present at the H.C. Wainwright 24th Annual Global Investment Conference SOUTH SAN FRANCISCO, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan…
seekingalpha.com Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q2 2022 Results - Earnings Call Transcript Calithera Biosciences, Inc. (NASDAQ:CALA ) Q2 2022 Earnings Conference Call August 15, 2022 5:00 PM ET Company Participants Stephanie Wong - Chief Financial Officer Susan Molineaux - Founder,…
investorplace.com What Is a Reverse Stock Split and How Does It Work? We've seen a spate of stock splits in 2022, including from high-profile companies, such as Amazon (NASDAQ: AMZN ) and Alphabet (NASDAQ: GOOG , NASDAQ: GOOGL ). But while a stock split may too…
investorplace.com What is a Reverse Stock Split and How Does it Work? Reverse stock splits are not that common and often are associated with some trouble brewing at the company. Therefore, one must do a thorough study before deciding what to do what with the stock of a…
globenewswire.com Calithera to Present at the H.C. Wainwright Global Investment Conference SOUTH SAN FRANCISCO, Calif., May 17, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan…
seekingalpha.com Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q1 2022 Results - Earnings Call Transcript Calithera Biosciences, Inc. (NASDAQ:CALA ) Q1 2022 Earnings Conference Call May 10, 2022 5:00 PM ET Company Participants Susan Molineaux - Founder, President & CEO Stephanie Wong - CFO Emil Kuriakose…
globenewswire.com Calithera Biosciences to Report First Quarter 2022 Financial Results on Tuesday, May 10, 2022 SOUTH SAN FRANCISCO, Calif., May 03, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that the…
pennystocks.com Best Penny Stocks to Buy Under $1 Now? 3 to Watch in May Are these under $1 penny stocks on your watchlist right now? The post Best Penny Stocks to Buy Under $1 Now?
seekingalpha.com Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q4 2021 Results - Earnings Call Transcript Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q4 2021 Results - Earnings Call Transcript
benzinga.com Calithera Biosciences Raises $10M Via Equity Issued At 10% Discount Calithera Biosciences Inc (NASDAQ: CALA) priced its previously announced underwritten public offering of 18.5 million shares at $0.54 per share for gross proceeds of $10 million. Each share of common…
